Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
1.130
-0.240 (-17.52%)
At close: Jul 17, 2026, 4:00 PM EDT
1.080
-0.050 (-4.42%)
After-hours: Jul 17, 2026, 7:53 PM EDT
Pomdoctor Revenue
In the year 2025, Pomdoctor had annual revenue of 399.92M CNY with 16.74% growth. Pomdoctor had revenue of 225.45M in the half year ending December 31, 2025, with 27.35% growth.
Revenue (ttm)
399.92M CNY
Revenue Growth
+16.74%
P/S Ratio
0.15
Revenue / Employee
2,423,727 CNY
Employees
165
Market Cap
8.42M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 399.92M | 57.36M | 16.74% |
| Dec 31, 2024 | 342.56M | 37.71M | 12.37% |
| Dec 31, 2023 | 304.85M | 59.64M | 24.32% |
| Dec 31, 2022 | 245.22M | 29.83M | 13.85% |
| Dec 31, 2021 | 215.39M | 74.18M | 52.53% |
| Dec 31, 2020 | 141.21M | -44.33M | -23.89% |
| Dec 31, 2019 | 185.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 450.13B |
| Johnson & Johnson | 97.93B |
| Eli Lilly and Company | 72.25B |
| AbbVie | 62.82B |
| Basel Medical Group | 11.46M |
| Bolt Biotherapeutics | 6.50M |
| BioRestorative Therapies | 357.87K |
| Aspire Biopharma Holdings | 34.56K |
POM News
- 4 days ago - POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities - PRNewsWire
- 6 days ago - PomDoctor regains Nasdaq compliance - TheFly
- 6 days ago - POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement - PRNewsWire
- 10 days ago - PomDoctor continues efforts to advance chronic disease management ecosystem - TheFly
- 10 days ago - POMDOCTOR LIMITED Continues to Advance AI-Enabled Chronic Disease Management Strategy Amid Growing Demand for Predictive Healthcare - PRNewsWire
- 17 days ago - POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services - PRNewsWire
- 4 weeks ago - PomDoctor Ltd – ADR trading halted, news pending - TheFly
- 4 weeks ago - POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026 - PRNewsWire